Daktronics Inc SEC Filings

John P. Friel, a director of Daktronics Inc. (DAKT), reported both a sale and a grant on 09/15/2025. He sold 13,479 shares of common stock at $23.5812 per share, and received a grant of 3,535 restricted shares at an indicated price of $24.04 that vest one year from the grant date. After these transactions his reported beneficial ownership is 77,629 shares (direct).

The Form 4 shows the sale reduced liquidity holdings but the restricted stock award increases his long-term stake subject to vesting. All details are presented as reported; no additional context, motives, or company guidance is included in the filing.

Insider acquisition reported: Shereta D. Williams, a director of Daktronics, acquired 3,535 shares of the company's common stock on 09/15/2025 at a price of $24.04 per share. After the transaction, Williams beneficially owns 47,040 shares. The reported shares are restricted stock that will vest one year from the grant date. The Form 4 was signed on 09/16/2025 and indicates the filing was made by one reporting person.

Jose-Marie Griffiths, a director of Daktronics, acquired 3,535 shares of common stock on 09/15/2025 at $24.04 per share, increasing her direct beneficial ownership to 61,030 shares. The acquisition is recorded as restricted stock that vests one year from the grant date, indicating the shares are subject to time-based vesting and not immediately transferable. The Form 4 shows the reporting person filed as an individual director and discloses no derivative transactions.

This filing documents an insider purchase rather than a sale, which can signal confidence by management, but the form does not provide company financial results or further context on the grant's purpose.

Neil D. Glat, a director of Daktronics Inc. (DAKT), reported an acquisition of 3,535 shares of common stock on 09/15/2025. The form shows the transaction was an acquisition at a reported price of $24.04 per share and that the shares are restricted stock that vests one year from the grant date. After the transaction Mr. Glat beneficially owned 3,535 shares in a direct capacity. The Form 4 was signed and dated 09/16/2025.

Form 144 notice from DAKTRONICS INC (DAKT): The filer reported a proposed sale of 13,479 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $317,850.99. The filing lists 48,530,238 shares outstanding and an approximate sale date of 09/15/2025 on NASDAQ. The securities to be sold were acquired as restricted stock on 08/23/2025 (7,160 shares) and 08/23/2024 (6,319 shares), both from the issuer, with payment dates matching acquisition dates. The filer certifies they are not aware of undisclosed material adverse information and includes the standard signature and legal notice regarding false statements.

The filing is an initial Form 3 from Neil D. Glat, reporting his relationship as a director of Daktronics Inc (DAKT). The form, dated 09/03/2025 for the event and signed 09/11/2025, states that no securities are beneficially owned by the reporting person. The form indicates it was filed by one reporting person and includes the reporting person's Brookings, SD address.

Daktronics, Inc. reported interim results for the quarter ended August 2, 2025, presenting condensed consolidated financial statements prepared under GAAP. The company held $136.9 million in cash and cash equivalents and reported product order backlog of $360.3 million, up from $267.2 million a year earlier and $341.6 million at fiscal year-end. Remaining performance obligations totaled $426.7 million, with roughly $369.4 million expected to be recognized within 12 months.

The company had no borrowings under a $60.0 million asset-based revolving credit facility and $41.5 million of available capacity after $2.5 million of letters of credit. Outstanding principal on the delayed draw term loan was $11.9 million. During the quarter Daktronics repurchased 0.6 million shares for $10.7 million and had $9.2 million remaining under the repurchase authorization. The effective tax rate for the quarter was 25.9 percent. Management noted provisions related to affiliate notes of $15,480 (previous quarter) and an additional $795 in the period, and equity-method investments carried a zero carrying value as of August 2, 2025.